Skip to main content
. 2013 Feb;57(2):723–733. doi: 10.1128/AAC.01403-12

Table 3.

Effects of genotype 1b HCV NS5A amino acid substitutions on DBPR110 potency

Amino acid substitution(s) Replication efficiency (%)a EC50 (pM)a Resistance at EC50 (n-fold) EC90 (pM)a Resistance at EC90 (n-fold)
None (parental) 100 1.5 ± 0.6 1 4.2 ± 2.1 1
P58S 42 ± 10 38 ± 14 25 64 ± 11 15
P58T 40 ± 15 243 ± 40 162 1303 ± 219 310
P58L 19 ± 8 564 ± 194 376 2731 ± 909 650
Y93N 8 ± 3 3,821 ± 1,677 2,547 13,305 ± 3,416 3,168
Y93H 8 ± 4 1,408 ± 293 939 7,337 ± 2,206 1,747
Y93C 9 ± 6 78 ± 40 52 177 ± 62 42
V153 M 70 ± 17 1.3 ± 0.5 1 4.1 ± 1.9 1
M202L 106 ± 37 2.1 ± 0.6 1 5.0 ± 1.4 1
M265V 87 ± 23 2.0 ± 0.9 1 5.1 ± 1.7 1
V153M M202L M265V 157 ± 52 1.1 ± 0.5 1 3.1 ± 1.1 1
Y93N V153M M202L M265V 16 ± 4 27,326 ± 12,349 18,217 98,912 ± 30,548 23,550
Y93H V153M M202L M265V 32 ± 10 8,736 ± 2,370 5,824 37,710 ± 6,970 8,979
a

Means ± standard deviations determined from transient transfection assays (n ≥ 3).